People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cytovia Holdings, Inc. | — | Biotechnology | Series A | $11.5M | $12.8M | 2022 |
Jason Aryeh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jason Aryeh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Wei Li | 1 | 7 |
| Michael Friedman | 1 | 4 |
| Thomas Robinson | 1 | 3 |
| Gregory Fiore | 1 | 3 |
| MICHAEL NOONAN | 1 | 3 |
| Laurent Audoly | 1 | 1 |
| Stanley Frankel | 1 | 1 |
| Daniel Teper | 1 | 1 |
| Armin Rath | 1 | 1 |
| Gilles Seydoux | 1 | 1 |
| Luca Scavo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.